Long-Acting Reversible Contraception(LARC) Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports

Long-Acting Reversible Contraception(LARC) Market Size
According to new survey, global Long-Acting Reversible Contraception(LARC) market is projected to reach US$ 1730.6 million in 2029, increasing from US$ 1154 million in 2022, with the CAGR of 6.0% during the period of 2023 to 2029.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-20M15682/Global_Long_Acting_Reversible_Contraception_LARC_Market_Research_Report_2023

Long-Acting Reversible Contraception(LARC) Market
Long-acting reversible pregnancy (LARC) is a birth control method that provides long-term pregnancy prevention. LARC can provide protection for three to 10 years or more.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Long-Acting Reversible Contraception(LARC) market with multiple angles, which provides sufficient supports to readers' strategy and decision making.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-20M15682/Global_Long_Acting_Reversible_Contraception_LARC_Market_Research_Report_2023

Segment by Type
• Intrauterine Devices (IUCs)
• Subcutaneous Implant

Segment by Application
• Age 20~24 Years Old
• Age 25-34 Years Old
• Age 35~44 Years Old
• Other

By Company
Bayer, Merck, Teva Pharmaceutical, Allergan, HRA Pharma, Eurogine, Yantai Family Planning Pharmaceutical Equipment Co., Ltd., Wuxi Tianyi Medical Equipment Co., Ltd., SMB Corporation, Shenyang Liren, Tianjin Hejie Medical Equipment Co., Ltd., Cooper Companies, AbbVie Allergan, Organon, Shanghai Dahua Pharmaceutical

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-20M15682/global-long-acting-reversible-contraception-larc

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.